Abstract: The present invention relates to novel triazene compounds, to a process for their preparation, to pharmaceutical compositions comprising them, and to the use thereof in the treatment of cancer diseases in humans. The novel triazene compounds are distinguished, as compared with the known triazene compounds, by improved activity while at the same time having reduced toxicity, that is to say by fewer side-effects.
Type:
Application
Filed:
July 3, 2008
Publication date:
September 16, 2010
Applicant:
TRIN PHARMA GMBH
Inventors:
Rudolf Reiter, Jochen Kalbe, Heinz Forster